FI965074A - Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä - Google Patents

Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä Download PDF

Info

Publication number
FI965074A
FI965074A FI965074A FI965074A FI965074A FI 965074 A FI965074 A FI 965074A FI 965074 A FI965074 A FI 965074A FI 965074 A FI965074 A FI 965074A FI 965074 A FI965074 A FI 965074A
Authority
FI
Finland
Prior art keywords
pct
inhibitors
aldoxine
tropane
derivatives
Prior art date
Application number
FI965074A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI965074A0 (fi
Inventor
Peter Moldt
Frank Watjen
Jorgen Scheel-Krueger
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of FI965074A0 publication Critical patent/FI965074A0/fi
Publication of FI965074A publication Critical patent/FI965074A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FI965074A 1994-04-19 1996-12-17 Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä FI965074A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK44794 1994-04-19
DK133894 1994-11-24
PCT/EP1995/001358 WO1995028401A1 (en) 1994-04-19 1995-04-12 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors

Publications (2)

Publication Number Publication Date
FI965074A0 FI965074A0 (fi) 1996-12-17
FI965074A true FI965074A (fi) 1996-12-17

Family

ID=26064021

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965074A FI965074A (fi) 1994-04-19 1996-12-17 Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä

Country Status (25)

Country Link
US (1) US5736556A (lv)
EP (1) EP0756596B1 (lv)
JP (1) JP2899418B2 (lv)
KR (1) KR100210417B1 (lv)
CN (1) CN1043763C (lv)
AT (1) ATE222587T1 (lv)
AU (1) AU690257B2 (lv)
BG (1) BG63259B1 (lv)
BR (1) BR9507489A (lv)
CA (1) CA2187309C (lv)
CZ (1) CZ284379B6 (lv)
DE (1) DE69527839T2 (lv)
DK (1) DK0756596T3 (lv)
EE (1) EE03877B1 (lv)
FI (1) FI965074A (lv)
GE (1) GEP19991749B (lv)
HU (1) HU215830B (lv)
LV (1) LV11738B (lv)
NO (1) NO964180L (lv)
NZ (1) NZ284075A (lv)
PL (1) PL183025B1 (lv)
RU (1) RU2134264C1 (lv)
SK (1) SK280875B6 (lv)
UA (1) UA49801C2 (lv)
WO (1) WO1995028401A1 (lv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283425B6 (sk) * 1995-10-13 2003-07-01 Neurosearch A/S Deriváty 8-azabicyklo[3,2,1]okt-2-énu, spôsob ich prípravy a použitia
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
SK282944B6 (sk) * 1995-11-02 2003-01-09 Neurosearch A/S Tavené tropánové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
US5948933A (en) 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
RU2167876C2 (ru) 1996-02-22 2001-05-27 Ньюросерч А/С 2,3-трансдизамещенное тропановое производное, способ его получения, фармацевтическая композиция
US6232326B1 (en) 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
WO2001003649A2 (en) 1999-07-13 2001-01-18 Alpha Research Group, Llc Compositions and methods for the treatment of parkinson's disease
IL152531A0 (en) * 2000-05-26 2003-05-29 Pfizer Tropane derivatives useful in therapy
US6667314B2 (en) 2000-05-26 2003-12-23 Pfizer, Inc. Tropane derivatives useful in therapy
EP1397358A1 (en) * 2001-05-23 2004-03-17 Neurosearch A/S Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
ATE345135T1 (de) * 2001-11-30 2006-12-15 Neurosearch As Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
AU2003265233B2 (en) * 2002-03-28 2008-05-08 Organix, Inc. Tropane compounds
CA2540834C (en) 2003-10-03 2010-06-22 Pfizer Inc. Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
MXPA06003762A (es) * 2003-10-16 2006-06-14 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de recaptacion de neurotransmisor monoamina y un inhibidor de acetilcolinesterasa.
EP1727547A1 (en) * 2004-01-22 2006-12-06 Neurosearch A/S Compounds for the sustained reduction of body weight
WO2005070429A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
WO2006075976A1 (fr) * 2005-01-14 2006-07-20 Private Enterprise 'slavyanskaya Klinika' Utilisation d'un anesthesique local pour corriger un comportement alimentaire humain, et procede d'utilisation associe
EP1779851A1 (en) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds

Also Published As

Publication number Publication date
PL183025B1 (pl) 2002-05-31
DK0756596T3 (da) 2002-12-23
CA2187309A1 (en) 1995-10-26
HU215830B (hu) 2001-05-28
JP2899418B2 (ja) 1999-06-02
GEP19991749B (en) 1999-09-10
NZ284075A (en) 1998-01-26
SK128896A3 (en) 1997-04-09
MX9604966A (es) 1998-05-31
UA49801C2 (uk) 2002-10-15
WO1995028401A1 (en) 1995-10-26
CA2187309C (en) 2000-11-21
CN1043763C (zh) 1999-06-23
KR100210417B1 (ko) 1999-07-15
BG100883A (en) 1998-03-31
BR9507489A (pt) 1997-08-12
EP0756596A1 (en) 1997-02-05
US5736556A (en) 1998-04-07
BG63259B1 (bg) 2001-07-31
CZ284379B6 (cs) 1998-11-11
CN1148854A (zh) 1997-04-30
RU2134264C1 (ru) 1999-08-10
FI965074A0 (fi) 1996-12-17
EP0756596B1 (en) 2002-08-21
DE69527839T2 (de) 2003-01-02
CZ298296A3 (en) 1997-06-11
NO964180L (no) 1996-12-16
EE9600132A (et) 1997-04-15
ATE222587T1 (de) 2002-09-15
DE69527839D1 (en) 2002-09-26
EE03877B1 (et) 2002-10-15
HUT75865A (en) 1997-05-28
AU2257595A (en) 1995-11-10
NO964180D0 (no) 1996-10-02
HU9602707D0 (en) 1996-11-28
PL316876A1 (en) 1997-02-17
LV11738A (lv) 1997-04-20
AU690257B2 (en) 1998-04-23
SK280875B6 (sk) 2000-08-14
LV11738B (en) 1997-12-20
JPH09505607A (ja) 1997-06-03

Similar Documents

Publication Publication Date Title
FI965074A (fi) Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä
CA2244773A1 (en) Tropane-derivatives, their preparation and use
BR9610960A (pt) Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
HRP20050213A2 (en) 2,4-substituted indoles and their use as 5-ht6 modulators
NO934761L (no) Antidepresjons- og antiparkinsonismeforbindelser
NO934760L (no) Arylsubstituerte heterosykliske forbindelser
CA2112061A1 (en) Alkyl substituted heterocyclic compounds
BR9607841A (pt) Método para a preparação de estéres de anidroeggonina

Legal Events

Date Code Title Description
NF Re-establishment of lapsed right